Revlimid Multiple Myeloma Trial Paused Due to Blood Clots
This article was originally published in The Pink Sheet Daily
Executive Summary
Celgene asserts that the Mayo Clinic study will resume within weeks, after the trial design is changed to require patients to receive aspirin prior to combo therapy of Revlimid/dexamethasone.